Science & Bio

Xaira Therapeutics

Xaira Therapeutics · #6 most active of 8 in Science & Bio

Compare →

Foundation-model-driven pipeline built on generative protein design and perturbation data.

67

Trust score · Mixed

3 data points checked · 2026-09-07

Model stack: DisputedEntry price: DisputedVersion: VerifiedHow this works →

Current version

X-Atlas/Pisces and X-Cell

Entry cost

Enterprise/proprietary drug discovery platform, no public pricing or individual tiers

Changes / 30d

6

The short answers · verified September 12, 2026

What is the latest version of Xaira Therapeutics?
The current shipped version of Xaira Therapeutics is X-Atlas/Pisces and X-Cell, as of September 12, 2026.
How much does Xaira Therapeutics cost?
Xaira Therapeutics has no published flat entry price. Enterprise/proprietary drug discovery platform, no public pricing or individual tiers
What AI model does Xaira Therapeutics use?
Xaira Therapeutics runs primarily on Proprietary.

Source: Xaira Therapeuticsxaira.com · Reusable under CC BY 4.0 — cite Tomorrow

Capabilities

  • Generative protein design
  • Perturbation atlases
  • Wet-lab loop
  • predictive AI models
  • agentic AI models
  • virtual cells
  • drug discovery
  • AI models for drug discovery
  • drug discovery AI
  • Predictive AI models
  • Agentic AI models
  • Drug discovery
  • Virtual cells
  • Drug discovery and development
  • Progressable Binders
  • predictive models
  • agentic models
  • predictive ai models
  • agentic ai models
  • AI drug discovery
  • Causal biological datasets
  • Drug discovery platform
  • causal biological datasets
  • Drug discovery AI
  • Preclinical development
  • Preclinical Development
  • Drug Discovery
  • X-Atlas/Pisces
  • X-Cell
  • preclinical development
  • Predictive models
  • Drug Discovery AI

Pricing

Enterprise/proprietary drug discovery platform, no public pricing or individual tiers

Entry price over time

8/7/2026 · $09/12/2026 · $0

Geek mode

Models under the hood

  • Proprietary

    Xaira

    inferred

Context window

Public API

no

Multi-model routing

no

Shared model stack

Other tracked products running on the same foundation models — a quick read on how much of the catalog moves when one of these models changes.

green disclosed · amber inferred · grey unattributed. Aliases are folded into one model; provider concentration counts only models with an established vendor.

Reported scale

Reference data. Each figure is whatever the source actually said — weekly users, downloads, revenue run-rate — with its own definition and date. These are not comparable between tools and are never used to rank anything.

No public usage figure on record for this product.

Also in Science & Bio

All Science & Bio
Lila Sciences

Lila SciencesUnited States

10

Autonomous science factories

Version
LILA
Cost
Pricing is not publicly disclosed. Contact Lila Sciences for custom enterprise solutions.
Model
LILA
Chai

Chai DiscoveryUnited States

9

Antibody and complex design

Version
1
Cost
Pricing is not publicly disclosed (enterprise/license agreements)
Model
Chai-1
FutureHouse

FutureHouseUnited States

8

Agents for scientific literature

Version
Robin
Cost
Free / Non-profit organization building open research tools and hosting a fellowship
Model
Multiple
Boltz

MITUnited States

7

Open structure prediction

Version
Boltz API
Cost
Pricing is not publicly disclosed (contact sales or try API)
Model
Boltz-2
Altos Labs

Altos LabsUnited States

6

Cellular rejuvenation research

Version
Cellular Rejuvenation Programming
Cost
Biotech company, not a software product. No commercial software/API pricing.
Model
Proprietary
ESM3

EvolutionaryScaleUnited States

3

Frontier protein language model

Version
ESM3
Cost
Available through the Biohub Platform API, with an open-source version (ESM3-open) available on GitHub.
Model
ESM Cambrian

Change history

  • capability

    New capabilities: Drug Discovery AI

    31 tracked32 tracked · +Drug Discovery AI

    source
  • capability

    New capabilities: Predictive models

    30 tracked31 tracked · +Predictive models

    source
  • capability

    New capabilities: preclinical development

    29 tracked30 tracked · +preclinical development

    source
  • capability

    New capabilities: Preclinical Development, Drug Discovery, X-Atlas/Pisces

    25 tracked29 tracked · +Preclinical Development, Drug Discovery, X-Atlas/Pisces, X-Cell

    source
  • version

    Xaira Therapeutics moved to X-Atlas/Pisces and X-Cell

    2026 platformX-Atlas/Pisces and X-Cell

    source
  • capability

    New capabilities: Drug discovery AI, Preclinical development

    23 tracked25 tracked · +Drug discovery AI, Preclinical development

    source
  • capability

    New capabilities: causal biological datasets

    22 tracked23 tracked · +causal biological datasets

    source
  • capability

    New capabilities: Drug discovery platform

    21 tracked22 tracked · +Drug discovery platform

    source
  • capability

    New capabilities: Causal biological datasets

    20 tracked21 tracked · +Causal biological datasets

    source
  • capability

    New capabilities: AI drug discovery

    19 tracked20 tracked · +AI drug discovery

    source
  • capability

    New capabilities: predictive ai models, agentic ai models

    17 tracked19 tracked · +predictive ai models, agentic ai models

    source
  • capability

    New capabilities: agentic models

    16 tracked17 tracked · +agentic models

    source
  • capability

    New capabilities: predictive models

    15 tracked16 tracked · +predictive models

    source
  • capability

    New capabilities: Drug discovery and development, Progressable Binders

    13 tracked15 tracked · +Drug discovery and development, Progressable Binders

    source
  • capability

    New capabilities: Predictive AI models, Agentic AI models, Drug discovery

    9 tracked13 tracked · +Predictive AI models, Agentic AI models, Drug discovery, Virtual cells

    source
  • capability

    New capabilities: drug discovery AI

    8 tracked9 tracked · +drug discovery AI

    source
  • capability

    New capabilities: AI models for drug discovery

    7 tracked8 tracked · +AI models for drug discovery

    source
  • capability

    New capabilities: predictive AI models, agentic AI models, virtual cells

    3 tracked7 tracked · +predictive AI models, agentic AI models, virtual cells, drug discovery

    source
  • version

    Xaira Therapeutics moved to X-Cell

    PlatformX-Cell

    source
  • capability

    New capabilities: X-Cell virtual cell model, causal perturbation model, drug discovery AI

    2 tracked5 tracked · +X-Cell virtual cell model, causal perturbation model, drug discovery AI

    source
  • version

    Xaira Therapeutics moved to Platform

    AI Drug Discovery PlatformPlatform

    source
  • capability

    New capabilities: AI drug discovery, computational biology platform

    2 tracked4 tracked · +AI drug discovery, computational biology platform

    source
Subscribe to Xaira Therapeutics changes

Xaira Therapeutics compared

Straight head-to-head pages against the busiest products in Science & Bio.

How to cite this page

Free to cite and reuse under CC BY 4.0. Permalink: https://tomorrow.aliensquad.ai/tools/xaira

APA
Tomorrow. (2026). Xaira Therapeutics — version, pricing and model stack [Data set entry]. AlienSquad. Retrieved 2026-09-13, from https://tomorrow.aliensquad.ai/tools/xaira
BibTeX
@misc{tomorrow-tools-xaira,
  author       = {{Tomorrow}},
  title        = {Xaira Therapeutics — version, pricing and model stack},
  year         = {2026},
  publisher    = {AlienSquad},
  howpublished = {\url{https://tomorrow.aliensquad.ai/tools/xaira}},
  note         = {Accessed: 2026-09-13}
}